Dynavax Technologies Corporation
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes o…
Drug Manufacturers - Specialty & Generic
US, EmeryVille [HQ]
Cash Flow Statement
15 Sheets · From 2023 to 2009Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -33.00 | -51.00 | -47.00 | -43.00 | -58.00 | -73.00 | -92.00 | -107.00 | -77.00 | -131.00 | -121.00 | -92.00 | 335.00 | 62.00 | 100.00 | |
| Operating Cash (Net) | -33.00 | -51.00 | -47.00 | -43.00 | -58.00 | -73.00 | -92.00 | -107.00 | -77.00 | -131.00 | -121.00 | -92.00 | 335.00 | 62.00 | 100.00 | |
| Accounts Receivable | 5.00 | - - | -8.00 | 8.00 | - - | - - | - - | - - | - - | 7.00 | -17.00 | -45.00 | -138.00 | -15.00 | 43.00 | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | -1.00 | 3.00 | 4.00 | -3.00 | - - | - - | 1.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -24.00 | -9.00 | -7.00 | 10.00 | -7.00 | 8.00 | - - | -12.00 | -1.00 | -11.00 | -33.00 | -32.00 | 172.00 | -298.00 | 61.00 | |
| Other WC | -31.00 | -12.00 | 3.00 | 1.00 | -4.00 | 5.00 | -10.00 | -2.00 | - - | -3.00 | 1.00 | 38.00 | 311.00 | -251.00 | 12.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | 19.00 | -50.00 | -34.00 | -39.00 | -51.00 | 90.00 | -85.00 | 86.00 | -108.00 | 55.00 | -42.00 | -26.00 | 14.00 | -315.00 | -153.00 | |
| Capital Expenditure | - - | - - | -1.00 | -2.00 | -1.00 | -1.00 | -6.00 | -7.00 | - - | -15.00 | -29.00 | -11.00 | -9.00 | -7.00 | -4.00 | |
| Purchases of Investments | -14.00 | -80.00 | -111.00 | -206.00 | -192.00 | -44.00 | -208.00 | -126.00 | -227.00 | -213.00 | -215.00 | -201.00 | -164.00 | -632.00 | -636.00 | |
| Sale/Maturity of Investment | 34.00 | 30.00 | 77.00 | 169.00 | 142.00 | 137.00 | 130.00 | 220.00 | 119.00 | 284.00 | 201.00 | 179.00 | 187.00 | 322.00 | 486.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | -1.00 | -2.00 | -1.00 | -1.00 | -6.00 | -7.00 | - - | -15.00 | -29.00 | -11.00 | -9.00 | -7.00 | -4.00 | |
| Acquisitions (Net) | -5.00 | -5.00 | - - | - - | - - | - - | - - | - - | - - | 11.00 | 7.00 | 7.00 | 1.00 | 1.00 | 1.00 | |
| Other Investing Activities | 5.00 | 5.00 | - - | - - | - - | - - | - - | - - | - - | -11.00 | -7.00 | - - | 1.00 | - - | - - | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -22.00 | -87.00 | -91.00 | -59.00 | -125.00 | -9.00 | -173.00 | - - | -187.00 | -99.00 | -154.00 | -109.00 | -55.00 | -19.00 | -1.00 | |
| Debt Repayment | - - | - - | - - | -15.00 | - - | - - | -10.00 | - - | - - | -99.00 | -74.00 | - - | -190.00 | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | 2.00 | 87.00 | 91.00 | 71.00 | 80.00 | - - | 183.00 | - - | 185.00 | - - | 65.00 | 108.00 | 28.00 | 9.00 | 6.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 19.00 | - - | - - | 2.00 | 44.00 | 9.00 | 1.00 | - - | 1.00 | 99.00 | 162.00 | - - | 217.00 | 9.00 | -4.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 28.00 | 36.00 | 22.00 | 31.00 | 7.00 | 23.00 | 49.00 | 44.00 | 24.00 | 27.00 | 49.00 | 40.00 | 32.00 | 436.00 | 202.00 | |
| End of Period | 36.00 | 22.00 | 31.00 | 7.00 | 23.00 | 49.00 | 44.00 | 24.00 | 26.00 | 49.00 | 40.00 | 32.00 | 436.00 | 202.00 | 150.00 | |
| Change | 8.00 | -14.00 | 9.00 | -24.00 | 15.00 | 26.00 | -4.00 | -20.00 | 2.00 | 22.00 | -9.00 | -7.00 | 404.00 | -234.00 | -51.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 9.00 | 7.00 | 6.00 | 7.00 | |
| Stock Based Compensation | 3.00 | 2.00 | 5.00 | 10.00 | 12.00 | 6.00 | 9.00 | 14.00 | 14.00 | - - | 25.00 | 13.00 | 21.00 | 32.00 | 42.00 | |
| Other | 19.00 | 10.00 | 1.00 | 2.00 | - - | - - | - - | - - | - - | 2.00 | 11.00 | 3.00 | 1.00 | -33.00 | 1.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -33.00 | -51.00 | -48.00 | -46.00 | -60.00 | -75.00 | -99.00 | -114.00 | -78.00 | -146.00 | -150.00 | -103.00 | 326.00 | 55.00 | 96.00 | |
| Cash Conversion Cycle (CCC) | -619.00 | -852.00 | -2,329.00 | - - | - - | - - | - - | - - | -338.00 | 395.00 | 695.00 | 1,761.00 | 232.00 | 152.00 | 419.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | -1.00 | - - | - - |